Karyopharm Therapeutics | KPTI - EPS Earnings Per Share


Karyopharm Therapeutics reported $-1.02 in EPS Earnings Per Share for its fiscal quarter ending in March of 2026.





Eps Change Date
AbbVie USD 3.65 1 Jun/2026
Abbott USD 1.31 0.16 Jun/2026
Amgen USD 6.29 1.14 Jun/2026
AstraZeneca USD 2.63 0.05 Jun/2026
BioCryst Pharmaceuticals USD 0.3 0.87 Jun/2026
Bristol-Myers Squibb USD 2.04 0.46 Jun/2026
Eli Lilly USD 8.38 0.17 Jun/2026
Enanta Pharmaceuticals USD -1.05 0.31 Dec/2024
GlaxoSmithKline GBP 0.51 0.08 Jun/2026
Incyte USD 3.09 1.28 Jun/2026
J&J USD 2.9 0.2 Jun/2026
Karyopharm Therapeutics USD -1.02 1.2 Mar/2026
MacroGenics USD -0.58 0.36 Mar/2026
Merck USD -0.13 1.15 Jun/2026
Nektar Therapeutics USD -1.78 0.43 Mar/2026
Novartis USD 2.41 0.42 Jun/2026
Novartis USD 1.99 0.45 Mar/2026
Pfizer USD 0.77 0.02 Jun/2026
Regeneron Pharmaceuticals USD 14.29 4.82 Jun/2026
Roche Holding CHF 10.98 2.61 Jun/2026
Sangamo BioSciences USD -0.18 0.1 Jun/2024
Takeda JPY 71.65 87.21 Jun/2026
Tectonic Therapeutic USD -1.34 0.32 Mar/2026
TG Therapeutics USD 0.05 0.07 Jun/2026
Ultragenyx Pharmaceutical USD -0.9 0.94 Jun/2026
Xencor USD -0.29 1.42 Jun/2026